2012
Psychiatrist Decision-Making Towards Prescribing Benzodiazepines: The Dilemma with Substance Abusers
Marienfeld CB, Tek E, Diaz E, Schottenfeld R, Chawarski M. Psychiatrist Decision-Making Towards Prescribing Benzodiazepines: The Dilemma with Substance Abusers. Psychiatric Quarterly 2012, 83: 521-529. PMID: 22528141, DOI: 10.1007/s11126-012-9220-8.Peer-Reviewed Original ResearchConceptsMental health centersPrescribing benzodiazepinesHealth centersPublic mental health centersSubstance abuseCommunity mental health centerUse of benzodiazepinesPercent of responsesOutpatient psychiatristsPatient characteristicsUnknown patientsPatient historyCommon reasonPatient useHistory of abuseBenzodiazepinesIllicit substancesSubstance abusersAnonymous surveyPatientsPsychiatristsPsychiatrists' decisionsAbusePrevious studies
2005
Effects of Ethnicity on Psychotropic Medications Adherence
Diaz E, Woods SW, Rosenheck RA. Effects of Ethnicity on Psychotropic Medications Adherence. Community Mental Health Journal 2005, 41: 521-537. PMID: 16142536, DOI: 10.1007/s10597-005-6359-x.Peer-Reviewed Original ResearchConceptsCommunity mental health centerMedication adherence ratesAdherence ratesHigh adherenceLow medication adherence ratesAfrican AmericansPsychotropic medication adherenceMental health centersMedication adherenceHealth centersLow adherenceDepressive symptomsEffect of ethnicityMonolingual HispanicsOlder ageAdherenceSignificant predictorsPast treatmentCaucasiansFurther studiesHispanicsMore yearsSymptoms
2003
Best Practices: Racial and Ethnic Effects on Antipsychotic Prescribing Practices in a Community Mental Health Center
Woods SW, Sullivan MC, Neuse EC, Diaz E, Baker CB, Madonick SH, Griffith EE, Steiner JL. Best Practices: Racial and Ethnic Effects on Antipsychotic Prescribing Practices in a Community Mental Health Center. Psychiatric Services 2003, 54: 177-179. PMID: 12556597, DOI: 10.1176/appi.ps.54.2.177.Peer-Reviewed Original ResearchConceptsCommunity mental health centerAntipsychotic prescribing practicesMental health centersPrescribing practicesHealth centersEthnic effects
2001
Perceived Needs and Service Use of Spanish Speaking Monolingual Patients Followed at a Hispanic Clinic
Diaz E, Prigerson H, Desai R, Rosenheck R. Perceived Needs and Service Use of Spanish Speaking Monolingual Patients Followed at a Hispanic Clinic. Community Mental Health Journal 2001, 37: 335-346. PMID: 11482751, DOI: 10.1023/a:1017552608517.Peer-Reviewed Original ResearchMeSH KeywordsAdultCommunication BarriersCommunity Mental Health CentersConnecticutCross-Sectional StudiesCultural DiversityEducational StatusFemaleHealth Care SurveysHealth Services, IndigenousHispanic or LatinoHumansLanguageMaleMiddle AgedNeeds AssessmentPatient CompliancePsychotropic DrugsSurveys and QuestionnairesConceptsMonolingual patientsPhysical health care providersMental health centersHealth care providersClinic patientsHealth centersAdditional interventionsCare providersService useHealth needsSociodemographic characteristicsNon-HispanicsPatientsClinicPerceived NeedsHispanicsPersistent effectsLow levelsBetter accessGreat needMedicationsMore difficultyLanguage barriers
2000
Effects of Divalproex Versus Lithium on Length of Hospital Stay Among Patients With Bipolar Disorder
Dalkilic A, Diaz E, Baker C, Pearsall H, Woods S. Effects of Divalproex Versus Lithium on Length of Hospital Stay Among Patients With Bipolar Disorder. Psychiatric Services 2000, 51: 1184-1186. PMID: 10970927, DOI: 10.1176/appi.ps.51.9.1184.Peer-Reviewed Original ResearchConceptsLength of stayBipolar disorderConnecticut Mental Health CenterLength of hospitalProspective Randomized StudyMental health centersDosages of neurolepticsRandomized studyBlood levelsMedical recordsHealth centersPractice guidelinesDivalproexStay variablesDisordersSignificant differencesPatientsStayDemographic variablesDosageDiagnostic variablesMonotherapyNeurolepticsInpatientsHospitalCharacteristics of Participants and Nonparticipants in Medication Trials for Treatment of Schizophrenia
Woods SW, Ziedonis DM, Sernyak MJ, Diaz E, Rosenheck RA. Characteristics of Participants and Nonparticipants in Medication Trials for Treatment of Schizophrenia. Psychiatric Services 2000, 51: 79-84. PMID: 10647137, DOI: 10.1176/ps.51.1.79.Peer-Reviewed Original ResearchConceptsSubstance use disordersTreatment of schizophreniaUse disordersAdministrative databasesEfficacy trialsTrial participantsDual diagnosisConcurrent substance use disordersCommunity mental health centerTreatment Efficacy TrialCharacteristics of patientsPoor treatment outcomesMental health centersCharacteristics of participantsMedical comorbiditiesMedication trialsTypes of trialsMale genderHealth centersService utilizationTreatment outcomesBetter outcomesPatientsTreatment efficacyYounger age